Showing results (61-70 of 184) with videos related to

Sort By:
Pageof 19
Cancer Chemotherapy and Pharmacology|May 14, 2017
Cellular effect and efficacy of carfilzomib depends on cellular net concentration gradientJulia Schäfer, Lukas Welti, Anja Seckinger, et al.
Journal of Receptor and Signal Transduction Research|November 28, 2019
Functional role of miR-148a in oropharyngeal cancer: influence on pregnane X receptor and P-glycoprotein expressionTasmin Reuter, Christel Herold-Mende, Gerhard Dyckhoff, et al.
Life (Basel, Switzerland)|August 26, 2023
Extracellular Vesicles as Surrogates for Drug Metabolism and Clearance: Promise vs. RealityAnna Gagliardi, Gzona Bajraktari-Sylejmani, Elisabetta Barocelli, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 17, 2016
Proteasome inhibition correlates with intracellular bortezomib concentrations but not with antiproliferative effects after bolus treatment in myeloma cell linesSusan Dettmer, Dirk Theile, Julia Schäfer, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 3, 2008
In vitro metabolism of the opioid tilidine and interaction of tilidine and nortilidine with CYP3A4, CYP2C19, and CYP2D6Johanna Weiss, Evelyn Sawa, Klaus-Dieter Riedel, et al.
Biochemical Pharmacology|March 3, 2007
Comparison of the inhibitory activity of anti-HIV drugs on P-glycoproteinCaroline Henrike Storch, Dirk Theile, Heike Lindenmaier, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 19, 2006
Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitorsJohanna Weiss, Dirk Theile, Nahal Ketabi-Kiyanvash, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 27, 2007
Plasma LDL cholesterol has no impact on P-glycoprotein (MDR1/ABCB1) activity in human peripheral blood mononuclear cellsCaroline Henrike Storch, Hans-Dieter Klimm, Tilman Heinrich, et al.
The Journal of Antimicrobial Chemotherapy|February 21, 2014
Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosingMichael J Dolton, Gerd Mikus, Johanna Weiss, et al.
Molecules (Basel, Switzerland)|November 9, 2024
A Highly Sensitive UPLC-MS/MS Method for the Quantification of the Organic Cation Transporters' Mediated Metformin Uptake and Its Inhibition in CellsGzona Bajraktari-Sylejmani, Cindy Bay, Lukas Gebauer, et al.
Pageof 19